1. Home
  2. IOVA vs EVER Comparison

IOVA vs EVER Comparison

Compare IOVA & EVER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOVA
  • EVER
  • Stock Information
  • Founded
  • IOVA 2007
  • EVER 2008
  • Country
  • IOVA United States
  • EVER United States
  • Employees
  • IOVA N/A
  • EVER N/A
  • Industry
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • EVER Computer Software: Programming Data Processing
  • Sector
  • IOVA Health Care
  • EVER Technology
  • Exchange
  • IOVA Nasdaq
  • EVER Nasdaq
  • Market Cap
  • IOVA 975.1M
  • EVER 924.1M
  • IPO Year
  • IOVA N/A
  • EVER 2018
  • Fundamental
  • Price
  • IOVA $2.47
  • EVER $25.84
  • Analyst Decision
  • IOVA Buy
  • EVER Strong Buy
  • Analyst Count
  • IOVA 12
  • EVER 4
  • Target Price
  • IOVA $10.36
  • EVER $32.50
  • AVG Volume (30 Days)
  • IOVA 20.9M
  • EVER 544.2K
  • Earning Date
  • IOVA 11-06-2025
  • EVER 11-03-2025
  • Dividend Yield
  • IOVA N/A
  • EVER N/A
  • EPS Growth
  • IOVA N/A
  • EVER 284.14
  • EPS
  • IOVA N/A
  • EVER 1.44
  • Revenue
  • IOVA $250,425,000.00
  • EVER $644,656,000.00
  • Revenue This Year
  • IOVA $65.15
  • EVER $32.27
  • Revenue Next Year
  • IOVA $58.47
  • EVER $11.05
  • P/E Ratio
  • IOVA N/A
  • EVER $17.97
  • Revenue Growth
  • IOVA 175.62
  • EVER 57.83
  • 52 Week Low
  • IOVA $1.64
  • EVER $16.63
  • 52 Week High
  • IOVA $9.70
  • EVER $30.03
  • Technical
  • Relative Strength Index (RSI)
  • IOVA 57.23
  • EVER 63.85
  • Support Level
  • IOVA $2.09
  • EVER $23.04
  • Resistance Level
  • IOVA $2.55
  • EVER $24.71
  • Average True Range (ATR)
  • IOVA 0.24
  • EVER 1.01
  • MACD
  • IOVA 0.01
  • EVER -0.01
  • Stochastic Oscillator
  • IOVA 61.59
  • EVER 79.13

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About EVER EverQuote Inc.

EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping, connecting consumers with insurance provider customers, which includes both carriers and agents. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.

Share on Social Networks: